Existing and Emerging Shorter-Acting Nondaily Hormonal Contraceptives
Dr. Kaunitz reports that his institution receives research funding from Agile, Bayer, and Teva, and that he is a consultant for Agile, Bayer, and Merck.
Dr. Nelson reports receiving grants/research funding from Bayer, Merck, Pfizer, and Teva; receiving speakers bureau honoraria from Bayer, Merck. and Teva; and being a consultant/advisory board member for Agile, Bayer, Ferring, Merck, Teva, and Watson.
Dr. Prabhakaran reports that she has no financial relationships to disclose.